C07K 14/5431
Il-11
Official title: {il-11}
C07K14/5431 (Il-11) appears on 79 US grants and 95 published applications in this corpus.
Search patents in C07K- Granted patents
- 79
- Published applications
- 95
- Assignees
- 40
- Inventors
- 122
- Latest grant
- 4 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 5 |
| 2004 | 1 | 9 |
| 2005 | 1 | 4 |
| 2006 | 3 | 1 |
| 2007 | 5 | 4 |
| 2008 | 4 | 8 |
| 2009 | 5 | 11 |
| 2010 | 5 | 7 |
| 2011 | 6 | 4 |
| 2012 | 6 | 5 |
| 2013 | 3 | 2 |
| 2014 | 4 | 2 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 2 | 1 |
| 2018 | 1 | 4 |
| 2019 | 4 | 7 |
| 2020 | 0 | 5 |
| 2021 | 4 | 4 |
| 2022 | 3 | 1 |
| 2023 | 3 | 1 |
| 2024 | 1 | 3 |
| 2025 | 1 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Decoy cytokine receptor4 Mar 2025US 12,240,889 B2National University of Singapore
- Methods of preparing a pegylated human IL-11 composition19 Mar 2024US 11,931,417 B2Nansha Biologics (Hong Kong) Limited
- Treatment and prevention of metabolic diseases14 Nov 2023US 11,813,311 B2National University of Singapore
- Treatment of SMC mediated disease10 Oct 2023US 11,780,898 B2National University of Singapore
- Systems and methods for production of recombinant IL-11 in yeast18 Apr 2023US 11,629,367 B2Nansha Biologies (HK) Limited
- Inhibitors of il11ra based signalling13 Aug 2026US 2026/0234199 A1
- Therapeutic cytokines and methods8 Jan 2026US 2026/0008830 A1Fundació Centre De Regulació GenòMica
- Decoy cytokine receptor16 Oct 2025US 2025/0320273 A1National University of Singapore
- Treatment and prevention of alcoholic liver disease20 Mar 2025US 2025/0092126 A1Boehringer Ingelheim International GmbH
- Bispecific binding agent-ligand fusions for the degradation of target proteins13 Jun 2024US 2024/0189423 A1The Regents of the University of California
Most cited
By later US patents
- Derivatives of growth hormone and related proteins160US 6,608,183 B1Bolder Biotechnology, Inc. · 2003
- Peptide and protein fusions to thioredoxin and thioredoxin-like molecules79US 5,270,181 AGenetics Institute, Inc. · 1993
- Peptide and protein fusions to thioredoxin and thioredoxin-like molecules54US 5,292,646 AGenetics Institute, Inc. · 1994
- Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules52US 5,646,016 AGenetics Institute, Inc. · 1997
- Cysteine variants of granulocyte-macrophage colony-stimulating factor45US 7,148,333 B2Bolder Biotechnology, Inc. · 2006